HC Wainwright Issues Pessimistic Forecast for Phathom Pharmaceuticals (NASDAQ:PHAT) Stock Price
Phathom Pharmaceuticals (NASDAQ:PHAT – Free Report) had its price objective lowered by HC Wainwright from $28.00 to $20.00 in a research report report published on Friday,Benzinga reports. The brokerage currently has a buy rating on the stock. PHAT has been the topic of several other research reports. Needham & Company LLC reiterated a “buy” rating […]
Phathom Pharmaceuticals (NASDAQ:PHAT – Free Report) had its price objective lowered by HC Wainwright from $28.00 to $20.00 in a research report report published on Friday,Benzinga reports. The brokerage currently has a buy rating on the stock. PHAT has been the topic of several other research reports. Needham & Company LLC reiterated a “buy” rating […]
